secwatch.observer — SEC 8-K summary
======================================

Issuer:     IR-Med, Inc. (—)
CIK:        0001839133
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001493152-24-023335
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IR-Med raises $715K in private placement, appoints director, increases authorized shares to 600M
--------------------------------------------------------------------------------

- Sold 715,000 common shares at $1.00 each and warrants to buy up to 1,144,000 shares at $1.00; gross proceeds $715,000.
- Warrants exercisable from 6-month anniversary, 5-year term; one-time dilution protection if later offering at lower price.
- Avital Rosenberg appointed Class I director and Audit Committee member; annual fee $5,000 plus $1,000 in-person / $300 virtual meeting fees.
- Authorized common shares increased from 250M to 600M via amendment filed June 6, approved by shareholders on November 7, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839133/000149315224023335/0001493152-24-023335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839133/000149315224023335/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer